EC Number   |
Inhibitors |
Structure |
|---|
    3.3.2.1 | (+/-)-3-[(carboxyethenyl)oxy]-6-hydroxy-1-benzoic acid |
i.e. 5-(1-carboxyvinyloxy)-2-hydroxybenzoic acid |
   |
| 3.3.2.1 | 3-[(carboxyethenyl)oxy]benzoic acid |
i.e. 3-(1-carboxyvinyloxy)benzoic acid |
|
| 3.3.2.1 | disodium 3-(2-carboxylatoethyl)benzoate |
- |
|
| 3.3.2.1 | disodium 3-[(E)-2-carboxylatoethenyl]benzoate |
- |
|
| 3.3.2.1 | Fe2+ |
- |
|
| 3.3.2.1 | more |
structure-based design of virulence inhibitors against Vibrio anguillarum, overview. The isochorismatase family can bind endogenous metabolite during the hetero-expression process, which is likely nicotinic acid, nicotinamide or pyrazinic acid, based on structural analysis and affinity prediction; structure-based design of virulence inhibitors against Vibrio anguillarum, overview. The isochorismatase family can bind endogenous metabolite during the hetero-expression process, which is likely nicotinic acid, nicotinamide or pyrazinic acid, based on structural analysis and affinity prediction |
|
